Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Ambry Genetics | RCV004444424 | SCV004927943 | uncertain significance | Inborn genetic diseases | 2024-02-02 | criteria provided, single submitter | clinical testing | The c.3002C>T (p.P1001L) alteration is located in exon 23 (coding exon 23) of the ADAMTS13 gene. This alteration results from a C to T substitution at nucleotide position 3002, causing the proline (P) at amino acid position 1001 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. |
Fulgent Genetics, |
RCV005040667 | SCV005678060 | uncertain significance | Upshaw-Schulman syndrome | 2024-01-05 | criteria provided, single submitter | clinical testing |